Shandong Xirang Biotechnology Development Co., Ltd. Is based on the forefront of the development of the inulin industry, with a research and development team of more than 20 people and more than 40000 square meters of intelligent, automated, and digital workshops.

Located on more than 20000 acres of the world's largest self operated and self managed Jerusalem artichoke planting base, the company specializes in Jerusalem artichoke cultivation, technological research and development, variety cultivation, saline alkali land improvement, Jerusalem artichoke feed, initial processing of Jerusalem artichoke, deep processing of healthy food of Jerusalem artichoke, and big health, digital tourism and other industries. It has achieved traceability and high standard control of all aspects of chrysanthemum powder from raw materials to end products, gradually building a fully integrated development model of the entire industry chain. The company is equipped with an IPO plan, benchmarking against the Beijing Stock Exchange, and is valued at over one billion yuan in three years.

At present, the company is planning to build a digital production workshop project with an annual output of 3500 tons of inulin, located at Ward Zhizao Port. The project is divided into three phases, with a first phase investment of 200 million yuan and an expected annual revenue of 280 million yuan. The project aims to make precise efforts in the inulin industry and deeply develop application scenarios in the inulin market. Guide the healthy development of China's inulin industry and build a leading enterprise in the industry.